yourstate.us
10 CFR 850.36

§ 850.36 Medical consent.

United States · 10 CFR — Energy · Status: effective

Get this as JSONEmbed this
Cite this
Citation
10 CFR 850.36, § 850.36 Medical consent, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/40971
Permanent ID
ys:prov:40971@1
SHA-256
93ab23f25906e186e4829a91e5fbcc0b32a522eb583e71da7b771fa1ea7173fb

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) The responsible employer must provide each beryllium-associated worker with a summary of the medical surveillance program established in § 850.34 at least one week before the first medical evaluation or procedure or at any time requested by the worker. This summary must include: (1) The type of data that will be collected in the medical surveillance program; (2) How the data will be collected and maintained; (3) The purpose for which the data will be used; and (4) A description of how confidential data will be protected. (b) Responsible employers must also provide each beryllium-associated worker with information on the benefits and risks of the medical tests and examinations available to the worker at least one week prior to any such examination or test, and an opportunity to have the worker's questions answered. (c) The responsible employer must have the SOMD obtain a beryllium-associated worker's signature on the informed consent form found in Appendix A to this part, before performing medical evaluations or any tests.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.